Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (21) Kammertöns, Thomas Dr. (3) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (6) Willimsky, Gerald Dr. (7) (-) Bunse, Mario Dr. (2) (-) Leisegang, Matthias Dr. (2) 2006 (1) (-) 2007 (1) (-) 2010 (1) 2011 (1) 2015 (2) (-) 2016 (2) 2017 (1) 2018 (2) 2020 (1) 2022 (1) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (4) Genetics, Nephrology, Hypertension, and Vascular Injury (1) Genetics of Metabolic and Reproductive Disorders (1) Genome Engineering & Disease Models (2) Genomics (1) Immune Regulation and Cancer (3) Mobile DNA (1) Molecular Cell Biology and Gene Therapy (10) (-) Molecular Immunology and Gene Therapy (4) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Signal Transduction in Development and Cancer (1) 4 Results: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Dr.Molecular Immunology and Gene Therapy200720102016 Sort: Result score Newest to oldest Oldest to newest May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
